Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-20

Clinical Trial Update: Lab School Day Study for CONCERTA of Older Children With ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial results for Concerta (methylphenidate extended-release) in older children with Attention-Deficit/Hyperactivity Disorder have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2011-01-20